Teneliximab (BMS-224819) is a chimeric monoclonal antibody, blocks the CD40-CD40L interaction. Teneliximab (BMS-224819) has partial agonist activity resulting in some signaling through CD40 and peripheral B cell depletion.
Purity:
>99.0%
CAS Number:
[299423-37-3]
* VAT and and shipping costs not included. Errors and price changes excepted
